This series of Annals of Translational Medicine is dedicated to the topic of “Stem Cell and Clinical Application”. We have attempted to shed light on some of the current clinical applications, strategies, mechanisms, and unsolved problems relating to stem cell therapy. Although there are still many challenges and questions that need to be addressed, we hope this series on the clinical application of stem cells will contribute to the growth of this field of study.
Editorial on Stem Cell and Clinical Application
The “Salmon Spirit” of translational medical research
Original Article on Stem Cell and Clinical Application
Glucosamine potentiates the differentiation of adipose-derived stem cells into glucose-responsive insulin-producing cells
Review Article on Stem Cell and Clinical Application
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
Mesenchymal stem cells to treat liver diseases
Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
Induced pluripotent stem cells for the treatment of liver diseases: challenges and perspectives from a clinical viewpoint
Liver regeneration and alcoholic liver disease
Responses of gastric epithelial stem cells and their niche to Helicobacter pylori infection
Engineering better stem cell therapies for treating heart diseases
Stem cells and stem cell-derived extracellular vesicles in acute and chronic kidney diseases: mechanisms of repair
Disclosure:
The series “Stem Cell and Clinical Application”was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Ling Lu served as the unpaid Guest Editor for the series.